Final patients to complete this double blinded trial by end of October. Top-Line trial results expected by year end. The InFoods IBS Diagnostic-Guided Therapy is the first therapy of its kind for treating all forms of IBS. InFoods IBS product addresses the… Read More
Biomerica Reports Fiscal 2021 Year End Results
Revenues increase 7.6% for fiscal 2021 vs fiscal 2020. InFoods IBS Endpoint Trial expected to be fully enrolled in less than 2 weeks. Biomerica receives multiple notices of allowance for patents covering the InFoods Technology Platform providing patent protection through… Read More
Biomerica Announces Notice of Allowance for Patent on Product used to Diagnose and Treat Depression
Hundreds of millions of people worldwide suffer from depression IRVINE, Calif., Aug. 11, 2021 (GLOBE NEWSWIRE) — Biomerica Inc. (NASDAQ: BMRA) announced today that the Japanese Patent Office has issued a notice of allowance for Biomerica’s first patent pertaining to… Read More